Research Article Details

Article ID: A24305
PMID: 23022698
Source: Clin Gastroenterol Hepatol
Title: Association between anthropometric parameters and measurements of liver stiffness by transient elastography.
Abstract: BACKGROUND & AIMS: We investigated the association between anthropometric parameters and results of liver stiffness measurements (LSMs) by transient elastography in healthy subjects and patients with nonalcoholic fatty liver disease (NAFLD). METHODS: We analyzed anthropometric and LSM data from 658 healthy subjects (37% male; mean age, 47 &#177; 11 years; body mass index [BMI], 21.8 &#177; 3.0 kg/m(2); LSM, 4.4 &#177; 1.6 kPa) and 247 patients with biopsy-proven NAFLD (50% male; mean age, 48 &#177; 11 years; BMI, 28.6 &#177; 6.5 kg/m(2); LSM, 9.6 &#177; 8.7 kPa). Healthy subjects were defined as individuals without viral hepatitis, alcoholic liver disease, or NAFLD. We investigated associations between anthropometric parameters, including BMI and waist circumference, and LSM. RESULTS: LSMs were slightly higher among healthy subjects with BMIs &#8804; 18.5 kg/m(2) (n = 84, 4.8 &#177; 1.5 kPa) and BMIs of 25-29.9 kg/m(2) (n = 76, 5.3 &#177; 2.2 kPa) than those with BMIs of 18.5-24.9 kg/m(2) (n = 492, 4.5 &#177; 1.9 kPa; P = .16 by analysis of variance). Among patients with NAFLD of Brunt fibrosis stage 0 or 1, LSMs were lowest among those with BMIs of 18.5-24.9 kg/m(2) (stage 0: n = 34, 5.5 &#177; 2.2 kPa; stage 1: n = 18, 7.2 &#177; 3.8 kPa). LSMs were higher among those with BMIs of 25-29.9 kg/m(2) (stage 0: n = 41, 6.1 &#177; 1.3 kPa; stage 1: n = 26, 7.9 &#177; 3.5 kPa) and highest for those with BMIs &#8805;30 kg/m(2) (stage 0: n = 13, 8.5 &#177; 2.2 kPa; stage 1: n = 22, 11.7 &#177; 5.2 kPa) (P < .001 and P = .002, respectively, by analysis of variance). High BMI was independently associated with high LSM, in addition to fibrosis stage, among patients with NAFLD. Patients with different waist circumferences had comparable LSMs. CONCLUSIONS: BMI &#8805;30 kg/m(2) is associated with higher LSMs in patients with NAFLD, after adjusting for fibrosis stage.
DOI: 10.1016/j.cgh.2012.09.025